prx-07034 prx-07034 prx-07034 is a selective 5-ht6 receptor antagonist. it has cognition and memory-enhancing properties and potently decreases food intake and body weight in rodents. prx-07034 was under development by epix pharmaceuticals for the treatment of obesity and cognitive impairment associated with alzheimer's disease and schizophrenia but upon the company collapsing due to lack of funds the compound was auctioned to another corporation. prx-07034clinical dataroutes ofadministrationoralatc codenonelegal statuslegal status in general: uncontrolled identifiers iupac name n--2-methylsulfonyl-5-piperazin-1-ylaniline cas number903580-16-5pubchem cid11532574chemspider9707357uniiyj5tmf911rchemical and physical dataformulac21h29cl2n3o4smolar mass490.44 g·mol−13d model (jsmol)interactive image smiles coc2cc(cl)cc(c2oc)c(c)nc1cc(ccc1s(=o)(=o)c)n3ccncc3 inchi inchi=1s/c21h28cln3o4s/c1-14(17-11-15(22)12-19(28-2)21(17)29-3)24-18-13-16(25-9-7-23-8-10-25)5-6-20(18)30(4,26)27/h5-6,11-14,23-24h,7-10h2,1-4h3key:bslxkmchxrcbih-uhfffaoysa-n (verify)